Briacell Therapeutics Corp Stock Price on October 23, 2024
| BCTX Stock | USD 0.62 0.03 4.62% |
Below is the normalized historical share price chart for Briacell Therapeutics Corp extending back to April 16, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Briacell Therapeutics stands at 0.62, as last reported on the 19th of December, with the highest price reaching 0.66 and the lowest price hitting 0.59 during the day.
If you're considering investing in Briacell Stock, it is important to understand the factors that can impact its price. Briacell Therapeutics appears to be very risky, given 3 months investment horizon. Briacell Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0576, which signifies that the company had a 0.0576% return per unit of risk over the last 3 months. By analyzing Briacell Therapeutics' technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please makes use of Briacell Therapeutics' Mean Deviation of 8.69, downside deviation of 11.3, and Risk Adjusted Performance of 0.0862 to double-check if our risk estimates are consistent with your expectations.
At this time, Briacell Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 10.3 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (2.3 M). . Price Earnings Ratio is likely to drop to -4.78 in 2024. Price Book Value Ratio is likely to rise to -29.72 in 2024. Briacell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of February 2021 | 200 Day MA 1.332 | 50 Day MA 0.8344 | Beta 1.816 |
Briacell |
Sharpe Ratio = 0.0576
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.64 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.73 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Briacell Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Briacell Therapeutics by adding it to a well-diversified portfolio.
Price Book 7.0593 | Book Value (0.13) | Enterprise Value 22.5 M | Enterprise Value Ebitda (1.38) | Shares Float 14.6 M |
Related Headline
Hepion Pharmaceuticals Headline on 23rd of October 2024
National Advertising Division Finds Certain HEPA Claims for ... by finance.yahoo.com
In a challenge brought by competitor Vesync Corporation dba Levoit, BBB National Programs National Advertising Division determined that Yalla Ventures, Inc. dba PuroAir provided a reasonable basis for claims that its PuroAir 400 air purifiers and filters have passed high-efficiency particulate air standards.New York, NY, Oct. 23, 2024 -- In a challenge brought by competitor Vesync Corporation dba Levoit, BBB National Programs National Advertising Division determin
Briacell Therapeutics Valuation on October 23, 2024
It is possible to determine the worth of Briacell Therapeutics on a given historical date. On October 23, 2024 Briacell was worth 0.86 at the beginning of the trading date compared to the closed value of 0.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Briacell Therapeutics stock. Still, in general, we apply an absolute valuation method to find Briacell Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Briacell Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Briacell Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.84 | 0.91 | 0.81 | 0.87 | 6,365,192 | |
10/23/2024 | 0.86 | 0.95 | 0.84 | 0.92 | 1,943,988 |
| 0.89 | 0.91 | 0.86 | 0.89 | 566,134 |
| Backtest Briacell Therapeutics | | | Briacell Therapeutics History | | | Briacell Therapeutics Valuation | Previous | Next |
Briacell Therapeutics Trading Date Momentum on October 23, 2024
| On October 24 2024 Briacell Therapeutics Corp was traded for 0.89 at the closing time. The top price for the day was 0.91 and the lowest listed price was 0.86 . The trading volume for the day was 566.1 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.26% . The overall trading delta against the current closing price is 15.22% . |
Briacell Therapeutics Fundamentals Correlations and Trends
By evaluating Briacell Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Briacell Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Briacell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Briacell Therapeutics Stock history
Briacell Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Briacell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Briacell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Briacell Therapeutics stock prices may prove useful in developing a viable investing in Briacell Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.5 M | 17.3 M | |
| Net Loss | -24.2 M | -22.9 M |
Briacell Therapeutics Stock Technical Analysis
Briacell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Briacell Therapeutics Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Briacell Therapeutics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Briacell Therapeutics December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Briacell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Briacell Therapeutics shares will generate the highest return on investment. By undertsting and applying Briacell Therapeutics stock market strength indicators, traders can identify Briacell Therapeutics Corp entry and exit signals to maximize returns
Briacell Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Briacell Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Briacell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Briacell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0862 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.9029 | |||
| Sortino Ratio | 0.105 | |||
| Treynor Ratio | 2.71 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Briacell Stock Analysis
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.